• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; PERMANENT DEFIBRILLATOR ELECTRODES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; PERMANENT DEFIBRILLATOR ELECTRODES Back to Search Results
Model Number 0286
Medical Device Problem Codes Fracture (1260); High impedance (1291); Pacing Problem (1439)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/29/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product has been received for analysis.Upon completion of the failure analysis of the complaint product, if there is any further relevant information from that review, a supplemental report will be filed.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited high pace impedance measurements along with a lack of rv pacing therefore no biventricular pacing was available to this patient.A lead fracture was suspected due to the high impedances however was not visualized on fluoroscopy.This rv lead was explanted and replaced with a new rv lead.No additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead exhibited high pace impedance measurements along with a lack of rv pacing therefore no biventricular pacing was available to this patient.A lead fracture was suspected due to the high impedances however was not visualized on fluoroscopy.This rv lead was explanted and replaced with a new rv lead.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and inner insulation integrity.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no anomalies.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE G
Common Device Name
PERMANENT DEFIBRILLATOR ELECTRODES
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key19103026
Report Number2124215-2024-22511
Device Sequence Number20689899
Product Code NVY
UDI-Device Identifier00802526431418
UDI-Public00802526431418
Combination Product (Y/N)Y
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
P910073/S077
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date01/19/2019
Device Model Number0286
Device Catalogue Number0286
Device Lot Number389195
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/04/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/29/2024
Supplement Date Received by Manufacturer05/23/2024
Initial Report FDA Received Date04/14/2024
Supplement Report FDA Received Date05/23/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/19/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age63 YR
Patient SexMale
-
-